Dashboard
Manage Tickers

INDVINDIVIOR PLC

Nasdaq www.indivior.com/en


$ 10.33 $ -0.74 (-6.67 %)    

Friday, 06-Sep-2024 15:59:48 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 446.25 $ -12.35 (-2.68 %)
DIA $ 404.28 $ -3.99 (-0.98 %)
SPY $ 539.90 $ -9.25 (-1.68 %)
TLT $ 99.49 $ -0.01 (-0.01 %)
GLD $ 230.65 $ -1.72 (-0.74 %)
$ 10.35
$ 10.33 x 300
$ 10.35 x 400
-- - --
$ 9.14 - $ 23.22
1,799,967
na
1.41B
$ 1.82
$ 706.52
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

smith--wesson-brands-reports-downbeat-results-joins-planet-labs-pbc-broadcom-and-other-big-stocks-moving-lower-in-fridays-pre-market-session
Smith & Wesson Brands Reports Downbeat Res...
09/06/2024 12:12:06

french-biotech-candidate-for-cannabis-use-disorder-fails-phase-2b-clinical-trial-indivior-will-not-exercise-option
French Biotech Candidate For Cannabis Use ...
09/05/2024 02:27:48

indivior-shares-update-on-aelis-farmas-phase-2b-study-with-aef0117-in-participants-with-cannabis-use-disorder
Indivior Shares Update On Aelis Farma's Ph...
09/04/2024 06:35:38

Primary and Secondary End Points of the Study were Not Met Indivior Does Not Currently Expect to Exercise AEF0117 Option 

nationwide-overdose-crisis-spurs-federal-funding-for-new-opioid-reversal-treatment
Nationwide Overdose Crisis Spurs Federal F...
08/27/2024 13:02:29

johnson-johnson-partner-addex-therapeutics-selects-investigational-compound-for-substance-use-disorder
Johnson Johnson-Partner Addex Therapeutics...
08/27/2024 12:48:04

Addex Therapeutics stock surged after announcing clinical candidate selection with Indivior for substance use disorder treatmen...

indivior-announces-bardas-first-order-of-opvee-nasal-spray-to-combat-opioids-and-aid-in-national-preparedness-barda-will-use-87m-in-project-bioshield-designated-funding-for-the-initial-procurement
Indivior Announces BARDA's First Order Of ...
08/26/2024 14:32:29

BARDA purchased OPVEE, a nalmefene opioid overdose reversal nasal sprayThrough BARDA's contract with Indivior, communities ...

dexcom-zynex-olin-and-other-big-stocks-moving-lower-in-fridays-pre-market-session
DexCom, Zynex, Olin And Other Big Stocks M...
07/26/2024 12:05:15

why-edwards-lifesciences-shares-are-trading-lower-here-are-other-stocks-moving-in-thursdays-mid-day-session
Why Edwards Lifesciences Shares Are Tradin...
07/25/2024 18:12:27

why-indivior-shares-are-trading-higher-here-are-20-stocks-moving-premarket
Why Indivior Shares Are Trading Higher; He...
07/25/2024 10:36:30

indivior-expects-2024-net-revenue-of-115b-1215b-vs-consensus-of-1215b-adjusted-gross-margin-of-low-mid-80-range-adjusted-operating-income-of-285m-320m
Indivior Expects 2024 Net Revenue Of $1.15...
07/25/2024 06:17:44

FY    2024    Guidance On    July    9th,    the    Group    updated    its  

indivior-announces-accelerated-100m-share-repurchase-program-targeting-completion-within-six-months
Indivior Announces Accelerated $100M Share...
07/25/2024 06:13:01

Repurchases Under Current Program now Expected to be Completed by End of July RICHMOND, Va., July 25, 2024 /PRNewswire/ -- ...

indivior-q2-eps-044-beats-014-estimate-sales-29900m-beat-29605m-estimate
Indivior Q2 EPS $0.44 Beats $0.14 Estimate...
07/25/2024 06:08:58

Indivior (NASDAQ:INDV) reported quarterly earnings of $0.44 per share which beat the analyst consensus estimate of $0.14 by 214...

piper-sandler-initiates-coverage-on-indivior-with-overweight-rating-announces-price-target-of-22
Piper Sandler Initiates Coverage On Indivi...
07/23/2024 09:48:20

Piper Sandler analyst David Amsellem initiates coverage on Indivior (NASDAQ:INDV) with a Overweight rating and announces Pri...

crossfirst-bankshares-posts-q2-earnings-joins-owens--minor-reddit-and-other-big-stocks-moving-lower-in-tuesdays-pre-market-session
CrossFirst Bankshares Posts Q2 Earnings, J...
07/16/2024 12:15:39

wells-fargo-posts-q2-earnings-joins-snowflake-and-other-big-stocks-moving-lower-in-fridays-pre-market-session
Wells Fargo Posts Q2 Earnings, Joins Snowf...
07/12/2024 12:20:50

craig-hallum-maintains-buy-on-indivior-lowers-price-target-to-24
Craig-Hallum Maintains Buy on Indivior, Lo...
07/10/2024 16:57:40

Craig-Hallum analyst Chase Knickerbocker maintains Indivior (NASDAQ:INDV) with a Buy and lowers the price target from $37 to...

sp-500-edges-higher-indivior-shares-plummet
S&P 500 Edges Higher; Indivior Shares Plummet
07/09/2024 18:38:34

why-helen-of-troy-shares-are-trading-lower-by-around-30-here-are-other-stocks-moving-in-tuesdays-mid-day-session
Why Helen of Troy Shares Are Trading Lower...
07/09/2024 16:59:31

crude-oil-down-1-soligenix-shares-surge
Crude Oil Down 1%; Soligenix Shares Surge
07/09/2024 16:11:44

whats-going-on-with-addiction-and-mental-illnesses-focused-indivior-stock-on-tuesday
What's Going On With Addiction And Mental ...
07/09/2024 15:59:54

Indivior lowers its profit forecast for 2024, discontinues sales of its schizophrenia drug Perseris, and announces job cuts, ca...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION